
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B28C8AF36BB305B28C001467D04C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmj">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362199/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="The BMJ">
<meta name="citation_title" content="Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial">
<meta name="citation_author" content="Bi-Cheng Liu">
<meta name="citation_author_institution" content="Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Zuo-Lin Li">
<meta name="citation_author_institution" content="Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Ping Zhang">
<meta name="citation_author_institution" content="Kidney Disease Centre, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China">
<meta name="citation_author" content="Ai-Min Zhong">
<meta name="citation_author_institution" content="Department of Nephrology, Jiangxi Provincial People’s Hospital, Nanchang, Jiangxi, China">
<meta name="citation_author" content="Ya-Ling Bai">
<meta name="citation_author_institution" content="Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China">
<meta name="citation_author" content="Yan Xu">
<meta name="citation_author_institution" content="Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China">
<meta name="citation_author" content="Bi-Hu Gao">
<meta name="citation_author_institution" content="Department of Nephrology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China">
<meta name="citation_author" content="Yan-Lin Li">
<meta name="citation_author_institution" content="Department of Nephrology, Zhongshan Traditional Chinese Medicine Hospital, Zhongshan, Guangdong, China">
<meta name="citation_author" content="Yu Wang">
<meta name="citation_author_institution" content="Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China">
<meta name="citation_author" content="Ling-Hui Zhou">
<meta name="citation_author_institution" content="Department of Nephrology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China">
<meta name="citation_author" content="Li Yao">
<meta name="citation_author_institution" content="Department of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China">
<meta name="citation_author" content="Jun-Xia Wang">
<meta name="citation_author_institution" content="Blood Purification Centre, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China">
<meta name="citation_author" content="Rui Yan">
<meta name="citation_author_institution" content="Department of Nephrology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China">
<meta name="citation_author" content="Liang Wang">
<meta name="citation_author_institution" content="Department of Nephrology, Wuxi People’s Hospital, Wuxi, Jiangsu, China">
<meta name="citation_author" content="Bing Liao">
<meta name="citation_author_institution" content="Department of Nephrology, The First People’s Hospital of Nanning, Nanning, Guangxi, China">
<meta name="citation_author" content="De-Qiong Xie">
<meta name="citation_author_institution" content="Department of Nephrology, Yibin Second People’s Hospital, Yibin, Sichuan, China">
<meta name="citation_author" content="Xiang-Ming Yi">
<meta name="citation_author_institution" content="Department of Nephrology, Yueyang People’s Hospital, Yueyang, Hunan, China">
<meta name="citation_author" content="Tian-Jun Guan">
<meta name="citation_author_institution" content="Department of Nephrology, Zhongshan Hospital Xiamen University, Xiamen, Fujian, China">
<meta name="citation_author" content="Cai-Li Wang">
<meta name="citation_author_institution" content="Department of Nephrology, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China">
<meta name="citation_author" content="Gui-Sen Li">
<meta name="citation_author_institution" content="Department of Nephrology, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China">
<meta name="citation_author" content="Fang-Qiong Li">
<meta name="citation_author_institution" content="Department of Research and Development of Haisco Pharmaceutical Group, Chengdu, Sichuan, China">
<meta name="citation_author" content="Jiang-Hua Chen">
<meta name="citation_author_institution" content="Kidney Disease Centre, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="390">
<meta name="citation_firstpage" content="e085208">
<meta name="citation_doi" content="10.1136/bmj-2025-085208">
<meta name="citation_pmid" content="40829896">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362199/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362199/">
<meta name="description" content="To evaluate the efficacy and safety of anrikefon (formerly known as HSK21542), a novel selective peripherally restricted kappa opioid receptor agonist, in patients with chronic kidney disease associated pruritus. Multicentre, double blind, ...">
<meta name="og:title" content="Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="To evaluate the efficacy and safety of anrikefon (formerly known as HSK21542), a novel selective peripherally restricted kappa opioid receptor agonist, in patients with chronic kidney disease associated pruritus. Multicentre, double blind, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362199/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12362199">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1136/bmj-2025-085208"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12362199%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12362199/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12362199/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362199/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmj.gif" alt="The BMJ logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to The BMJ" title="Link to The BMJ" shape="default" href="https://www.bmj.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMJ</button></div>. 2025 Aug 19;390:e085208. doi: <a href="https://doi.org/10.1136/bmj-2025-085208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1136/bmj-2025-085208</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMJ%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMJ%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMJ%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMJ%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20BC%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Bi-Cheng Liu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Bi-Cheng Liu</span></h3>
<div class="p">
<sup>1</sup>Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20BC%22%5BAuthor%5D" class="usa-link"><span class="name western">Bi-Cheng Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20ZL%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Zuo-Lin Li</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Zuo-Lin Li</span></h3>
<div class="p">
<sup>1</sup>Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China</div>
<div>consultant nephrologist</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20ZL%22%5BAuthor%5D" class="usa-link"><span class="name western">Zuo-Lin Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ping Zhang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ping Zhang</span></h3>
<div class="p">
<sup>2</sup>Kidney Disease Centre, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Ping Zhang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ai-Min Zhong</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ai-Min Zhong</span></h3>
<div class="p">
<sup>3</sup>Department of Nephrology, Jiangxi Provincial People’s Hospital, Nanchang, Jiangxi, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Ai-Min Zhong</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bai%20YL%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Ya-Ling Bai</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Ya-Ling Bai</span></h3>
<div class="p">
<sup>4</sup>Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bai%20YL%22%5BAuthor%5D" class="usa-link"><span class="name western">Ya-Ling Bai</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Yan Xu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Yan Xu</span></h3>
<div class="p">
<sup>5</sup>Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan Xu</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20BH%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Bi-Hu Gao</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Bi-Hu Gao</span></h3>
<div class="p">
<sup>6</sup>Department of Nephrology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20BH%22%5BAuthor%5D" class="usa-link"><span class="name western">Bi-Hu Gao</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20YL%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Yan-Lin Li</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Yan-Lin Li</span></h3>
<div class="p">
<sup>7</sup>Department of Nephrology, Zhongshan Traditional Chinese Medicine Hospital, Zhongshan, Guangdong, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20YL%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan-Lin Li</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yu Wang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yu Wang</span></h3>
<div class="p">
<sup>8</sup>Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yu Wang</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20LH%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Ling-Hui Zhou</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Ling-Hui Zhou</span></h3>
<div class="p">
<sup>9</sup>Department of Nephrology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20LH%22%5BAuthor%5D" class="usa-link"><span class="name western">Ling-Hui Zhou</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Li Yao</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Li Yao</span></h3>
<div class="p">
<sup>10</sup>Department of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Li Yao</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20JX%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Jun-Xia Wang</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Jun-Xia Wang</span></h3>
<div class="p">
<sup>11</sup>Blood Purification Centre, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20JX%22%5BAuthor%5D" class="usa-link"><span class="name western">Jun-Xia Wang</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Rui Yan</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Rui Yan</span></h3>
<div class="p">
<sup>12</sup>Department of Nephrology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rui Yan</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Liang Wang</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Liang Wang</span></h3>
<div class="p">
<sup>13</sup>Department of Nephrology, Wuxi People’s Hospital, Wuxi, Jiangsu, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Liang Wang</span></a>
</div>
</div>
<sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Bing Liao</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Bing Liao</span></h3>
<div class="p">
<sup>14</sup>Department of Nephrology, The First People’s Hospital of Nanning, Nanning, Guangxi, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bing Liao</span></a>
</div>
</div>
<sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xie%20DQ%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">De-Qiong Xie</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">De-Qiong Xie</span></h3>
<div class="p">
<sup>15</sup>Department of Nephrology, Yibin Second People’s Hospital<strong>,</strong> Yibin<strong>,</strong> Sichuan, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xie%20DQ%22%5BAuthor%5D" class="usa-link"><span class="name western">De-Qiong Xie</span></a>
</div>
</div>
<sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yi%20XM%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Xiang-Ming Yi</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Xiang-Ming Yi</span></h3>
<div class="p">
<sup>16</sup>Department of Nephrology, Yueyang People’s Hospital, Yueyang, Hunan, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yi%20XM%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiang-Ming Yi</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guan%20TJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Tian-Jun Guan</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Tian-Jun Guan</span></h3>
<div class="p">
<sup>17</sup>Department of Nephrology, Zhongshan Hospital Xiamen University, Xiamen, Fujian, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guan%20TJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Tian-Jun Guan</span></a>
</div>
</div>
<sup>17</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20CL%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Cai-Li Wang</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Cai-Li Wang</span></h3>
<div class="p">
<sup>18</sup>Department of Nephrology, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20CL%22%5BAuthor%5D" class="usa-link"><span class="name western">Cai-Li Wang</span></a>
</div>
</div>
<sup>18</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20GS%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Gui-Sen Li</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Gui-Sen Li</span></h3>
<div class="p">
<sup>19</sup>Department of Nephrology, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20GS%22%5BAuthor%5D" class="usa-link"><span class="name western">Gui-Sen Li</span></a>
</div>
</div>
<sup>19</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20FQ%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Fang-Qiong Li</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Fang-Qiong Li</span></h3>
<div class="p">
<sup>20</sup>Department of Research and Development of Haisco Pharmaceutical Group, Chengdu, Sichuan, China</div>
<div>vice general manager</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20FQ%22%5BAuthor%5D" class="usa-link"><span class="name western">Fang-Qiong Li</span></a>
</div>
</div>
<sup>20</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20JH%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Jiang-Hua Chen</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Jiang-Hua Chen</span></h3>
<div class="p">
<sup>2</sup>Kidney Disease Centre, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China</div>
<div>professor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20JH%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiang-Hua Chen</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>, <span class="on-behalf-of">on behalf of the Anrikefon-302 study collaborator group</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China</div>
<div id="aff2">
<sup>2</sup>Kidney Disease Centre, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China</div>
<div id="aff3">
<sup>3</sup>Department of Nephrology, Jiangxi Provincial People’s Hospital, Nanchang, Jiangxi, China</div>
<div id="aff4">
<sup>4</sup>Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China</div>
<div id="aff5">
<sup>5</sup>Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China</div>
<div id="aff6">
<sup>6</sup>Department of Nephrology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China</div>
<div id="aff7">
<sup>7</sup>Department of Nephrology, Zhongshan Traditional Chinese Medicine Hospital, Zhongshan, Guangdong, China</div>
<div id="aff8">
<sup>8</sup>Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China</div>
<div id="aff9">
<sup>9</sup>Department of Nephrology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China</div>
<div id="aff10">
<sup>10</sup>Department of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China</div>
<div id="aff11">
<sup>11</sup>Blood Purification Centre, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China</div>
<div id="aff12">
<sup>12</sup>Department of Nephrology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China</div>
<div id="aff13">
<sup>13</sup>Department of Nephrology, Wuxi People’s Hospital, Wuxi, Jiangsu, China</div>
<div id="aff14">
<sup>14</sup>Department of Nephrology, The First People’s Hospital of Nanning, Nanning, Guangxi, China</div>
<div id="aff15">
<sup>15</sup>Department of Nephrology, Yibin Second People’s Hospital<strong>,</strong> Yibin<strong>,</strong> Sichuan, China</div>
<div id="aff16">
<sup>16</sup>Department of Nephrology, Yueyang People’s Hospital, Yueyang, Hunan, China</div>
<div id="aff17">
<sup>17</sup>Department of Nephrology, Zhongshan Hospital Xiamen University, Xiamen, Fujian, China</div>
<div id="aff18">
<sup>18</sup>Department of Nephrology, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China</div>
<div id="aff19">
<sup>19</sup>Department of Nephrology, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China</div>
<div id="aff20">
<sup>20</sup>Department of Research and Development of Haisco Pharmaceutical Group, Chengdu, Sichuan, China</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Correspondence to: J-H Chen <span>chenjianghua@zju.edu.cn</span>
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Bi-Cheng Liu</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Zuo-Lin Li</span></strong>: <span class="role">consultant nephrologist</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ping Zhang</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ai-Min Zhong</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ya-Ling Bai</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Yan Xu</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Bi-Hu Gao</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Yan-Lin Li</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Yu Wang</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ling-Hui Zhou</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Li Yao</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jun-Xia Wang</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Rui Yan</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Liang Wang</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Bing Liao</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">De-Qiong Xie</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Xiang-Ming Yi</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Tian-Jun Guan</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Cai-Li Wang</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Gui-Sen Li</span></strong>: <span class="role">professor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Fang-Qiong Li</span></strong>: <span class="role">vice general manager</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jiang-Hua Chen</span></strong>: <span class="role">professor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Accepted 2025 Jul 3; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</div>
<p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12362199  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40829896/" class="usa-link">40829896</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objective</h3>
<p>To evaluate the efficacy and safety of anrikefon (formerly known as HSK21542), a novel selective peripherally restricted kappa opioid receptor agonist, in patients with chronic kidney disease associated pruritus.</p></section><section id="sec2"><h3 class="pmc_sec_title">Design</h3>
<p>Multicentre, double blind, randomised placebo controlled phase 3 trial.</p></section><section id="sec3"><h3 class="pmc_sec_title">Setting</h3>
<p>50 centres in China, June 2022 to June 2024.</p></section><section id="sec4"><h3 class="pmc_sec_title">Participants</h3>
<p>652 patients with moderate to severe CKD associated pruritus undergoing haemodialysis were screened: 545 were randomly assigned (1:1 ratio) to receive either anrikefon (n=275) or placebo (n=270).</p></section><section id="sec5"><h3 class="pmc_sec_title">Interventions</h3>
<p>Intravenous anrikefon (0.3 μg/kg body weight) or placebo three times weekly for 12 weeks, followed by an optional open label extension phase with anrikefon treatment for 40 weeks.</p></section><section id="sec6"><h3 class="pmc_sec_title">Main outcome measures</h3>
<p>The primary endpoint was the percentage of patients achieving at least a 4 point reduction in weekly mean 24 hour worst itching intensity numerical rating scale (WI-NRS) score from baseline to week 12. Secondary outcomes were the percentage of patients achieving at least a 3 point reduction in weekly mean WI-NRS score from baseline to week 12, as well as changes in itch related quality of life from baseline using the Skindex-10 and 5-D itch scales. The change in itch related quality of life from baseline to week 40 of open label treatment was also reported using the 5-D itch scale. The safety of anrikefon was evaluated throughout the trial.</p></section><section id="sec7"><h3 class="pmc_sec_title">Results</h3>
<p>243/275 (88%) patients in the anrikefon group and 254/270 (94%) in the placebo group completed the 12 week double blind treatment. 443 subsequently entered the 40 week open label extension phase. 37% of patients in the anrikefon group showed at least a 4 point reduction in WI-NRS score at week 12 compared with 15% in the placebo group (P&lt;0.001). The percentage of patients with at least a 3 point reduction in WI-NRS score from baseline to week 12 was 51% in the anrikefon group compared with 24% in the placebo group (P&lt;0.001). The anrikefon group showed significant improvements in itch related quality of life (mean change from baseline in 5-D itch scale −5.3 <em>v</em> −3.1, P&lt;0.001 and in Skindex-10 scale −15.2 <em>v</em> −9.3, P&lt;0.001). Anrikefon also showed sustained long term efficacy during the open label extension phase at week 40, with persistent improvement in quality of life scores on the 5-D itch scale. Mild to moderate dizziness was more common in the anrikefon group than placebo group but without evident clinical consequences.</p></section><section id="sec8"><h3 class="pmc_sec_title">Conclusions</h3>
<p>In patients with moderate to severe pruritus undergoing haemodialysis, anrikefon was found to be safe and resulted in a noticeable reduction in itch intensity and an improvement in itch related quality of life.</p></section><section id="sec9"><h3 class="pmc_sec_title">Trial registration</h3>
<p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT05135390" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05135390</a>.</p></section></section><section id="sec10"><h2 class="pmc_sec_title">Introduction</h2>
<p>Chronic kidney disease (CKD) associated pruritus is a common and distressing condition in patients with advanced disease, especially those undergoing renal replacement therapy. CKD associated pruritus affects more than 60% of patients undergoing haemodialysis, with 33-50% reporting moderate to severe itching.<a href="#ref1" class="usa-link" aria-describedby="ref1"><sup>1</sup></a>
<a href="#ref2" class="usa-link" aria-describedby="ref2"><sup>2</sup></a>
<a href="#ref3" class="usa-link" aria-describedby="ref3"><sup>3</sup></a>
<a href="#ref4" class="usa-link" aria-describedby="ref4"><sup>4</sup></a> Pruritus not only worsens the quality of life of these patients but also leads to higher mortality rates.<a href="#ref5" class="usa-link" aria-describedby="ref5"><sup>5</sup></a>
<a href="#ref6" class="usa-link" aria-describedby="ref6"><sup>6</sup></a> As shown in a large international study, pruritus in patients undergoing haemodialysis was associated with a 17% higher mortality risk.<a href="#ref7" class="usa-link" aria-describedby="ref7"><sup>7</sup></a> Thus, novel effective treatment strategies need to be evaluated, given the substantial side effects of off-label treatments used to manage CKD associated pruritus.</p>
<p>Although the pathogenesis of CKD associated pruritus remains unclear, many risk factors, such as immune dysregulation, accumulation of uraemic toxins, and imbalances in the endogenous opioid system, are thought to be contributory factors.<a href="#ref8" class="usa-link" aria-describedby="ref8"><sup>8</sup></a>
<a href="#ref9" class="usa-link" aria-describedby="ref9"><sup>9</sup></a> Notably, the imbalance between kappa opioid receptor and mu opioid receptor signalling is considered to play a crucial role in the development of pruritus.<a href="#ref10" class="usa-link" aria-describedby="ref10"><sup>10</sup></a> Moreover, targeting peripherally distributed kappa opioid receptors is considered a promising treatment strategy for CKD associated pruritus.<a href="#ref11" class="usa-link" aria-describedby="ref11"><sup>11</sup></a>
</p>
<p>Anrikefon (formerly known as HSK21542) is a novel selective peripherally restricted kappa opioid receptor agonist that exerts antinociceptive and antipruritic effects by activating peripheral kappa opioid receptors.<a href="#ref12" class="usa-link" aria-describedby="ref12"><sup>12</sup></a> Anrikefon has a hydrophilic small peptide and spirocyclic structure that enhances its binding affinity to the kappa opioid receptor, resulting in minimal penetration of the blood-brain barrier.<a href="#ref13" class="usa-link" aria-describedby="ref13"><sup>13</sup></a> Thus, anrikefon can potentially reduce the systemic side effects that are commonly associated with activation of kappa opioid receptors in the central nervous system. A previous phase 2 trial involving patients receiving haemodialysis and with moderate to severe pruritus showed clinically meaningful reductions in itch intensity and statistically significant improvements in itch related quality of life in the anrikefon group compared with placebo group.<a href="#ref14" class="usa-link" aria-describedby="ref14"><sup>14</sup></a> We conducted a phase 3 trial to evaluate the efficacy and safety of anrikefon in patients with moderate to severe pruritus undergoing haemodialysis.</p></section><section id="sec11"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec12"><h3 class="pmc_sec_title">Trial sites and patient selection</h3>
<p>This phase 3 multicentre double blind randomised placebo controlled trial was conducted at 50 sites in China. The trial comprised a double blind treatment phase for 12 weeks, followed by an optional open label extension phase with anrikefon treatment for 40 weeks.</p>
<p>Eligible patients for the double blind phase were adults (≥18 years) undergoing haemodialysis three times weekly for at least three months, with a dry body weight (ie, patients neither overhydrated or underhydrated, as determined by the doctor) of 40-135 kg and moderate to severe pruritus. We defined moderate to severe pruritus as a weekly mean score of &gt;5 on the 24 hour worst itching intensity numerical rating scale (WI-NRS). The mean score was calculated from daily assessments during a week’s run-in period before randomisation. Notably, concomitant use of antihistamines, corticosteroids, calcineurin inhibitors, gabapentin, or pregabalin was permitted if doses had been maintained at stable levels for at least seven days before screening. Also, concomitant use of antipsychotics, sedatives, hypnotics, selective serotonin reuptake inhibitors, antianxiety drugs, or tricyclic antidepressants was permitted if doses had been maintained at stable levels for at least 14 days before screening. Initiation of new antipruritic drugs after the screening visit was prohibited. The supplementary appendix details the eligibility criteria. All the patients signed informed consent forms before trial participation.</p></section><section id="sec13"><h3 class="pmc_sec_title">Trial design and assessments</h3>
<p>Eligible patients were randomised in a 1:1 ratio to receive either intravenous anrikefon or placebo at a dose of 0.3 μg/kg three times weekly for 12 weeks. Any participant who underwent an extra dialysis session in any given week received a supplementary dose of anrikefon or placebo, with a maximum of four doses weekly. The dosage was calculated based on the patient’s dry body weight, which was assessed every four weeks. Anrikefon or placebo was administered intravenously within one hour after the dialysis session, either through the dialysis circuit or through an arm without a fistula or a non-fistula vessel in the arm with a fistula. Randomisation and blinding were performed using a computer generated sequence and stratified by baseline WI-NRS score (&lt;7 (moderate itching) and ≥7 (severe itching)) to ensure that the groups were well balanced for disease severity.</p>
<p>After the completion of the 12 week double blind phase (see fig 1), eligible patients in both randomisation groups were invited to participate in an open label extension phase of anrikefon treatment for 40 weeks (see fig 2). Anrikefon was administered to all patients according to the principles of the double blind phase.</p></section><section id="sec14"><h3 class="pmc_sec_title">Trial oversight</h3>
<p>The trial was conducted in accordance with the principles of the Declaration of Helsinki and the Good Clinical Practice guidelines. The institutional review board at each participating institution approved the trial protocol. All the patients provided written informed consent before trial participation. An independent data monitoring committee was established for this trial, which periodically reviewed all the data. The committee conducted an unblinded futility analysis after 182 participants had received treatment for 12 weeks and their 24 hour WI-NRS weekly average values were available. The results of the interim analysis supported the independent data monitoring committee’s decision to continue the trial.</p></section><section id="sec15"><h3 class="pmc_sec_title">Efficacy outcomes</h3>
<p>The primary endpoint was the percentage of patients achieving a reduction of ≥4 points in weekly mean 24 hour WI-NRS score from baseline to week 12. Secondary endpoints were the percentage of patients achieving at least a 3 point reduction in weekly mean WI-NRS score from baseline to week 12, and changes in itch related quality of life from baseline using the Skindex-10 and 5-D itch scales. Additionally, we also evaluated the changes from baseline in the 5-D itch scale during the open label extension phase. The safety of anrikefon was evaluated throughout the 12 week double blind treatment phase, as well as during the 40 week open label extension phase, providing insights into its long term safety profile. Here, preferred terms in the Medical Dictionary for Regulatory Activities, version 27.0, were used for the documentation of adverse events.<a href="#ref15" class="usa-link" aria-describedby="ref15"><sup>15</sup></a> The common terminology criteria for adverse events (CTCAE), version 5.0, were used for assessment of severity.<a href="#ref16" class="usa-link" aria-describedby="ref16"><sup>16</sup></a>
</p></section><section id="sec16"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>The sample size for the trial was determined based on the results from a phase 2 clinical trial (Anrikefon-203), which indicated at least a 4 point decrease from baseline to week 12 in the weekly mean WI-NRS score for the anrikefon 0.30 μg/kg group compared with placebo group, with a difference of 13% (data not published). Using a one sided test with a significance level of 0.025 and a power of 80%, a total of 434 participants were required to detect a difference in the primary endpoint. Considering a 20% dropout rate, we aimed to enrol study 544 participants.</p>
<p>The primary analysis was conducted on the full analysis dataset from the double blind treatment phase, with data handling according to the multiple imputation strategy for missing data (see supplementary table S1). For each imputed complete dataset, a logistic regression model was applied, using at least a 4 point change from baseline to week 12 in the weekly mean WI-NRS score as the dependent variable, the treatment group as the independent variable, and the baseline WI-NRS score as a covariate. Different additional strategies were used to analyse the primary endpoint in the full analysis and per protocol datasets to show the robustness of the results. The odds ratio for the anrikefon group versus the placebo group, along with its standard error (SE), was calculated from 100 imputed datasets. Rubin’s rule was then used to combine the results, yielding a pooled odds ratio, the corresponding 95% confidence interval, and the P value. If the lower limit of the 95% CI was &gt;1, it indicated that the anrikefon group has a higher likelihood of response (the difference from baseline in WI-NRS ≥4 points) at week 12 compared with the placebo group, suggesting that the response rate of anrikefon is superior at week 12. We computed the least squares mean changes from baseline and corresponding 95% CIs for each treatment group. All statistical analyses were performed using SAS software (version 9.4).</p>
<p>For the secondary endpoints, we analysed the mean changes from baseline to week 12 in the total scores of the 5-D itch and Skindex-10 scales using a repeated measures mixed effects model, with the trial group as a fixed effect, and the baseline score and stratification factors as covariates. Using the same logistic regression model that was used for the primary outcome, we analysed the percentage of patients with at least a 3 point reduction in the weekly mean WI-NRS score from baseline to week 12.</p>
<p>Safety was evaluated by monitoring adverse events, vital signs, clinical laboratory measurements, and electrocardiograms throughout the study period. All patients who underwent randomisation and received at least one dose of the study drug were included in the safety analysis. The incidence and severity of treatment emergent adverse events were recorded and analysed in the context of the study treatment.</p></section><section id="sec17"><h3 class="pmc_sec_title">Patient and public involvement</h3>
<p>No funding was allocated for involvement of patients or the public in the design, conduct, reporting, or dissemination plans of this trial. However, the participants were aware of the purpose of the trial during recruitment. Although there was no direct patient and public involvement in this paper owing to funding restrictions, we did speak to patients about the study, and we asked a member of the public to read our manuscript after submission.</p></section></section><section id="sec18"><h2 class="pmc_sec_title">Results</h2>
<section id="sec19"><h3 class="pmc_sec_title">Trial participants</h3>
<p>Of 652 patients screened, 545 were randomly assigned to receive either anrikefon (n=275) or placebo (n=270) between June 2022 and June 2024. Among these, 544 participants were included in the full analysis dataset. One patient was excluded owing to lack of post-dose efficacy assessments. Finally, 243 (88%) patients in the anrikefon group and 254 (94%) in the placebo group completed the 12 week double blind treatment (<a href="#f1" class="usa-link">fig 1</a>). Subsequently, 443 patients entered the 40 week open label extension phase (<a href="#f2" class="usa-link">fig 2</a>). The study population comprised predominantly men (70%), with a mean age of 52.7 years. The baseline weekly mean WI-NRS score was 7.0 (standard deviation (SD 1.1). More than half of the participants (52%) had a WI-NRS score of at least 7 at baseline. The baseline characteristics of the two groups were comparable (<a href="#tbl1" class="usa-link">table 1</a>). Moreover, the rate of concomitant use of antipruritic drugs was comparable between the two groups (see supplementary table S2).</p>
<figure class="fig xbox font-sm" id="f1"><h4 class="obj_head">Fig 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362199_liub085208.f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194f/12362199/603fe6036321/liub085208.f1.jpg" loading="lazy" height="187" width="800" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overall study design of phase 3 clinical trial of anrikefon in patients with moderate to severe pruritus undergoing haemodialysis. *Visit dates coincided with patients’ regular dialysis days, with at least one day between each of the planned visits. WI-NRS=worst itching intensity numerical rating scale</p></figcaption></figure><figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">Fig 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362199_liub085208.f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194f/12362199/1fb6b9eca207/liub085208.f2.jpg" loading="lazy" height="943" width="708" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Patient flow chart. *Patients could have multiple reasons for being excluded during screening. †Participants missed three consecutive doses of study drug in either week 11 or week 12 or missed six consecutive doses of study drug throughout the entire treatment period. ‡Deaths due to disease progression during treatment period</p></figcaption></figure><section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline personal and disease characteristics of participants with chronic kidney disease associated pruritus undergoing haemodialysis assigned to receive anrikefon or placebo. Values are number (percentage) unless stated otherwise</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="above" rules="groups">
<col width="51.69%" span="1">
<col width="24.99%" span="1">
<col width="23.32%" span="1">
<thead><tr>
<th valign="top" align="left" scope="col" colspan="1" rowspan="1">Characteristics</th>
<th valign="top" align="center" scope="col" colspan="1" rowspan="1">Anrikefon (n=275)</th>
<th valign="top" align="center" scope="col" colspan="1" rowspan="1">Placebo (n=269)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" scope="col" colspan="1" rowspan="1">Sex:</td>
<td valign="top" align="left" colspan="1" rowspan="1"></td>
<td valign="top" align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> Men</td>
<td valign="top" align="center" colspan="1" rowspan="1">195 (71)</td>
<td valign="top" align="center" colspan="1" rowspan="1">185 (69)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> Women</td>
<td valign="top" align="center" colspan="1" rowspan="1">80 (29)</td>
<td valign="top" align="center" colspan="1" rowspan="1">84 (31)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" colspan="1" rowspan="1">Age (years):</td>
<td valign="top" align="left" colspan="1" rowspan="1"></td>
<td valign="top" align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> Mean (SD)</td>
<td valign="top" align="center" colspan="1" rowspan="1">51.8 (10.7)</td>
<td valign="top" align="center" colspan="1" rowspan="1">53.6 (11.2)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> &lt;65</td>
<td valign="top" align="center" colspan="1" rowspan="1">237 (86)</td>
<td valign="top" align="center" colspan="1" rowspan="1">219 (81)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> ≥65</td>
<td valign="top" align="center" colspan="1" rowspan="1">38 (14)</td>
<td valign="top" align="center" colspan="1" rowspan="1">50 (19)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Mean (SD) height (cm)</td>
<td valign="top" align="center" colspan="1" rowspan="1">166.3 (7.9)</td>
<td valign="top" align="center" colspan="1" rowspan="1">166.2 (7.7)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Mean (SD) dry body weight (kg)*</td>
<td valign="top" align="center" colspan="1" rowspan="1">62.3 (11.9)</td>
<td valign="top" align="center" colspan="1" rowspan="1">62.9 (12.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Mean (SD) blood analyte testing:</td>
<td valign="top" align="center" colspan="1" rowspan="1"> </td>
<td valign="top" align="center" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> Calcium (mmol/L)</td>
<td valign="top" align="center" colspan="1" rowspan="1">2.3 (0.2)</td>
<td valign="top" align="center" colspan="1" rowspan="1">2.3 (0.2)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> Phosphorus (mmol/L)</td>
<td valign="top" align="center" colspan="1" rowspan="1">2.0 (0.6)</td>
<td valign="top" align="center" colspan="1" rowspan="1">2.0 (0.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" colspan="1" rowspan="1">Weekly WI-NRS score (range 0-10)†:</td>
<td valign="top" align="left" colspan="1" rowspan="1"></td>
<td valign="top" align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> Mean (SD)</td>
<td valign="top" align="center" colspan="1" rowspan="1">7.0 (1.0)</td>
<td valign="top" align="center" colspan="1" rowspan="1">7.0 (1.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> &lt;7</td>
<td valign="top" align="center" colspan="1" rowspan="1">132 (48)</td>
<td valign="top" align="center" colspan="1" rowspan="1">129 (48)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1"> ≥7</td>
<td valign="top" align="center" colspan="1" rowspan="1">143 (52)</td>
<td valign="top" align="center" colspan="1" rowspan="1">140 (52)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Mean (SD) Skindex-10 scale score (range 0-60)‡</td>
<td valign="top" align="center" colspan="1" rowspan="1">30.1 (12.4)</td>
<td valign="top" align="center" colspan="1" rowspan="1">29.1 (12.9)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Mean (SD) 5-D itch scale (range 5-25)‡</td>
<td valign="top" align="center" colspan="1" rowspan="1">16.0 (2.9)</td>
<td valign="top" align="center" colspan="1" rowspan="1">15.9 (3.0)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="_fn_p28"><p>SD=standard deviation; WI-NRS=worst itching intensity numerical rating scale.</p></div>
<div class="fn" id="t1n1">
<sup>*</sup><p class="display-inline">Body weight at which the patient’s volume shows neither overhydration nor underhydration, as determined by the doctor. At each dialysis session, fluid was removed to lower the patient’s body weight to this prescribed dry weight.</p>
</div>
<div class="fn" id="t1n2">
<sup>†</sup><p class="display-inline">Measures worst itching intensity during previous 24 hours; higher scores indicate greater intensity of itching.</p>
</div>
<div class="fn" id="t1n3">
<sup>‡</sup><p class="display-inline">Higher scores indicate worse itch related quality of life.</p>
</div>
</div></section></section><section id="sec20"><h3 class="pmc_sec_title">Primary endpoint</h3>
<p>Anrikefon resulted in significant improvements in the primary outcome compared with placebo. The percentage of participants in the anrikefon group who achieved at least a 4 point improvement from baseline on the 24 hour WI-NRS was 37% (95% CI 31% to 43%) compared with 15% (11% to 19%) in the placebo group. The odds ratio for the anrikefon group versus placebo group was 3.56 (95% CI 2.30 to 5.50), with a P&lt;0.001 (<a href="#f3" class="usa-link">fig 3</a>). Results of additional analyses of the primary outcome matched with the primary analysis (see supplementary table S3).</p>
<figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">Fig 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362199_liub085208.f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194f/12362199/57bcb76b1f43/liub085208.f3.jpg" loading="lazy" height="548" width="710" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Proportion of patients in anrikefon and placebo groups at week 12 with at least a 4 point reduction from baseline in weekly mean 24 hour WI-NRS score (A) and at least a 3 point reduction from baseline in weekly mean WI-NRS score (B). Mean change from baseline in Skindex-10 scale (C) and 5-D itch scale (D) total score at 12 weeks. The Skindex-10 scale is a validated instrument designed to measure the impact of skin disease on patients’ quality of life. The 5-D itch scale measures five dimensions of itch: degree, duration, direction, disability, and distribution. Whiskers represent standard errors. P values were calculated using χ<sup>2</sup> test (A and B) and analysis of covariance (C and D). WI-NRS=worst itching intensity numerical rating scale</p></figcaption></figure><p>Analysis of subgroups defined by baseline WI-NRS score, age, and sex showed that, with the exception of the subgroup of 65 years or older, all other subgroups showed statistically significant differences in the percentage of participants achieving a ≥4 point reduction in WI-NRS score from baseline to week 12 between the anrikefon and placebo groups (see supplementary figure S1).</p></section><section id="sec21"><h3 class="pmc_sec_title">Secondary endpoints</h3>
<p>The percentage of participants achieving a ≥3 point improvement from baseline on the WI-NRS at week 12 was significantly higher in the anrikefon group (51%, 95% CI 45% to 57%) compared with placebo group (24%, 19% to 29%). The odds ratio for the anrikefon group versus placebo group was 3.34 (95% CI 2.29 to 4.87, P&lt;0.001) (<a href="#f3" class="usa-link">fig 3</a>). The least squares mean difference in change from baseline in weekly mean WI-NRS scores at week 12 between the anrikefon group and placebo group was −1.5 (95% CI −1.90 to −1.20, P&lt;0.001). Moreover, a statistically significant improvement in mean WI-NRS starting at week 2 was sustained through 12 weeks of treatment (<a href="#f4" class="usa-link">fig 4</a>). Notably, the greatest change from baseline occurred at the 12th week. Supplementary figure S2 shows the absolute mean WI-NRS score for each group over the 12 week double blind period.</p>
<figure class="fig xbox font-sm" id="f4"><h4 class="obj_head">Fig 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194f/12362199/8baae5d328e3/liub085208.f4.jpg" loading="lazy" height="372" width="704" alt="Fig 4"></p>
<div class="p text-right font-secondary"><a href="figure/f4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mean change from baseline in 24 hour WI-NRS score over 12 weeks in anrikefon and placebo groups. Whiskers represent 95% confidence intervals. WI-NRS=worst itching intensity numerical rating scale</p></figcaption></figure><p>The anrikefon group showed significant improvements in itch related quality of life at week 12 using the Skindex-10 and 5-D itch scales compared with placebo group (<a href="#f5" class="usa-link">fig 5</a> and <a href="#f6" class="usa-link">fig 6</a>). For example, the least squares mean change from baseline in the Skindex-10 total score at week 12 was −15.2 (SE 0.7) in the anrikefon group and −9.3 (0.69) in the placebo group (<a href="#f5" class="usa-link">fig 5</a>), with a between group difference of −5.9 (95% CI −7.88 to −4.02, P&lt;0.001). Similarly, the least squares mean change from baseline in the 5-D itch total score at week 12 was −5.3 (SE 0.21) in the anrikefon group and −3.1 (0.21) in the placebo group, with a between group difference of −2.2 (95% CI −2.77 to −1.62, P&lt;0.001) (<a href="#f6" class="usa-link">fig 6</a>).</p>
<figure class="fig xbox font-sm" id="f5"><h4 class="obj_head">Fig 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194f/12362199/4bb55195420e/liub085208.f5.jpg" loading="lazy" height="371" width="704" alt="Fig 5"></p>
<div class="p text-right font-secondary"><a href="figure/f5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mean change from baseline in Skindex-10 total score over 12 weeks in anrikefon and placebo groups. Whiskers represent 95% confidence intervals</p></figcaption></figure><figure class="fig xbox font-sm" id="f6"><h4 class="obj_head">Fig 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194f/12362199/335bc3c227f0/liub085208.f6.jpg" loading="lazy" height="372" width="704" alt="Fig 6"></p>
<div class="p text-right font-secondary"><a href="figure/f6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mean change from baseline in 5-D itch total score over 52 weeks. Whiskers represent 95% confidence intervals</p></figcaption></figure><p>At week 40 of the open label extension phase, 356 participants showed a persistent improvement in quality of life scores on the 5-D itch scale, showing sustained efficacy of anrikefon (<a href="#f5" class="usa-link">fig 5</a>). Specifically, the change from baseline during the double blind phase for the 176 participants in the anrikefon group was −7.8 (SD 3.37) points, and for the 180 participants in the placebo group was −7.6 (SD 3.18) points.</p></section><section id="sec22"><h3 class="pmc_sec_title">Drug use and adverse events</h3>
<p>A total of 502 participants received anrikefon, with the longest duration of use for 374 days. During the double blind treatment phase, the incidence of treatment emergent adverse events was comparable between the anrikefon and placebo groups [228 (83%) and 222 (82%) participants, respectively]. Twenty participants (7%) in the anrikefon group and 12 (4%) in the placebo group discontinued treatment owing to treatment emergent adverse events. Fifty participants (18%) in the anrikefon group had CTCAE (common terminology criteria for adverse events) grade ≥3 treatment emergent adverse events compared with 56 participants (21%) in the placebo group. The most common drug related adverse event in patients receiving anrikefon was dizziness, which was generally mild to moderate and resolved without evident clinical consequences. Other common adverse events such as hyperkalaemia, dialysis related hypotension, hypotension, and muscle cramps were comparable between the two groups (<a href="#tbl2" class="usa-link">table 2</a>). In the open label extension phase, 410 participants (93%) reported treatment emergent adverse events, with 92 (21%) experiencing treatment emergent adverse events related to the study drug. The incidence of severe treatment emergent adverse events (CTCAE grade ≥3) was 42%, affecting four participants (1%) (<a href="#tbl3" class="usa-link">table 3</a>). The incidence of clinically relevant abnormalities in vital signs, laboratory test results, or electrocardiographic findings were comparable between the two groups. The types of adverse events were largely similar between the double blind treatment phase and the open label extension phase (see supplementary tables S4 and S5 for detailed data).</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Adverse events during double blind phase in participants with chronic kidney disease associated pruritus undergoing haemodialysis assigned to receive anrikefon or placebo</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="above" rules="groups">
<col width="60.25%" span="1">
<col width="20.48%" span="1">
<col width="19.27%" span="1">
<thead>
<tr>
<th rowspan="2" valign="top" align="left" scope="col" colspan="1">Double blind phase</th>
<th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">No (%)</th>
</tr>
<tr>
<th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Anrikefon (n=275)</th>
<th valign="top" align="center" scope="col" colspan="1" rowspan="1">Placebo (n=270)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Any adverse event*</td>
<td valign="top" align="center" colspan="1" rowspan="1">228 (83)</td>
<td valign="top" align="center" colspan="1" rowspan="1">222 (82)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">TEAEs</td>
<td valign="top" align="center" colspan="1" rowspan="1">228 (83)</td>
<td valign="top" align="center" colspan="1" rowspan="1">222 (82)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Treatment related adverse events</td>
<td valign="top" align="center" colspan="1" rowspan="1">71 (26)</td>
<td valign="top" align="center" colspan="1" rowspan="1">47 (17)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Grade ≥3 TEAEs</td>
<td valign="top" align="center" colspan="1" rowspan="1">50 (18)</td>
<td valign="top" align="center" colspan="1" rowspan="1">56 (21)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">TEAEs leading to temporary discontinuation of study drug</td>
<td valign="top" align="center" colspan="1" rowspan="1">20 (7)</td>
<td valign="top" align="center" colspan="1" rowspan="1">12 (4)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">TEAEs leading to study discontinuation</td>
<td valign="top" align="center" colspan="1" rowspan="1">7 (3)</td>
<td valign="top" align="center" colspan="1" rowspan="1">5 (2)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Most frequent adverse events†</td>
<td valign="top" align="center" colspan="1" rowspan="1"> </td>
<td valign="top" align="center" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Hyperkalaemia</td>
<td valign="top" align="center" colspan="1" rowspan="1">48 (17)</td>
<td valign="top" align="center" colspan="1" rowspan="1">37 (14)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Hypoglycaemia</td>
<td valign="top" align="center" colspan="1" rowspan="1">15 (5)</td>
<td valign="top" align="center" colspan="1" rowspan="1">12 (4)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Dialysis related hypotension</td>
<td valign="top" align="center" colspan="1" rowspan="1">40 (15)</td>
<td valign="top" align="center" colspan="1" rowspan="1">31 (11)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Hypotension</td>
<td valign="top" align="center" colspan="1" rowspan="1">33 (12)</td>
<td valign="top" align="center" colspan="1" rowspan="1">28 (10)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Hypertension</td>
<td valign="top" align="center" colspan="1" rowspan="1">13 (5)</td>
<td valign="top" align="center" colspan="1" rowspan="1">16 (6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Covid-19</td>
<td valign="top" align="center" colspan="1" rowspan="1">29 (11)</td>
<td valign="top" align="center" colspan="1" rowspan="1">34 (13)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Upper respiratory tract infection</td>
<td valign="top" align="center" colspan="1" rowspan="1">10 (4)</td>
<td valign="top" align="center" colspan="1" rowspan="1">19 (7)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Muscle cramps</td>
<td valign="top" align="center" colspan="1" rowspan="1">31 (11)</td>
<td valign="top" align="center" colspan="1" rowspan="1">24 (9)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Dizziness</td>
<td valign="top" align="center" colspan="1" rowspan="1">28 (10)</td>
<td valign="top" align="center" colspan="1" rowspan="1">13 (5)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Chest discomfort</td>
<td valign="top" align="center" colspan="1" rowspan="1">17 (6)</td>
<td valign="top" align="center" colspan="1" rowspan="1">11 (4)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Serious adverse events</td>
<td valign="top" align="center" colspan="1" rowspan="1">37 (13)</td>
<td valign="top" align="center" colspan="1" rowspan="1">36 (13)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Death</td>
<td valign="top" align="center" colspan="1" rowspan="1">3 (1)</td>
<td valign="top" align="center" colspan="1" rowspan="1">5 (2)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="_fn_p43">
<p>TEAEs=treatment emergent adverse events.</p>
<p>The double blind phase is defined as all patients who had undergone randomisation and received at least one dose of placebo or anrikefon between randomisation and end of 12 week double blind intervention period.</p>
</div>
<div class="fn" id="t2n1">
<sup>*</sup><p class="display-inline">Preferred terms in the Medical Dictionary for Regulatory Activities, version 27.0, were used for the documentation of adverse events.<a href="#ref15" class="usa-link" aria-describedby="ref15"><sup>15</sup></a>
</p>
</div>
<div class="fn" id="t2n2">
<sup>†</sup><p class="display-inline">Defined as those with an incidence &gt;5% in either group. See supplementary table S4 for adverse events that were reported in at least 1.5% of patients.</p>
</div>
</div></section><section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Adverse events during open label phase in participants with chronic kidney disease associated pruritus undergoing haemodialysis assigned to receive anrikefon or placebo</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="above" rules="groups">
<col width="60.25%" span="1">
<col width="39.75%" span="1">
<thead><tr>
<th valign="top" align="left" scope="col" colspan="1" rowspan="1">Open label phase</th>
<th valign="top" align="center" scope="col" colspan="1" rowspan="1">No (%) of participants (n=442)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Any adverse event</td>
<td valign="top" align="center" colspan="1" rowspan="1">410 (93)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">TEAEs</td>
<td valign="top" align="center" colspan="1" rowspan="1">410 (93)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Treatment related adverse events</td>
<td valign="top" align="center" colspan="1" rowspan="1">92 (21)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Grade ≥3 TEAEs</td>
<td valign="top" align="center" colspan="1" rowspan="1">187 (42)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">TEAEs leading to temporary discontinuation of study drug</td>
<td valign="top" align="center" colspan="1" rowspan="1">80 (18)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">TEAEs leading to study discontinuation</td>
<td valign="top" align="center" colspan="1" rowspan="1">35 (8)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Serious adverse events</td>
<td valign="top" align="center" colspan="1" rowspan="1">153 (35)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" colspan="1" rowspan="1">Death</td>
<td valign="top" align="center" colspan="1" rowspan="1">20 (4)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p48">
<p>TEAEs=treatment emergent adverse events.</p>
<p>The open label phase is defined as patients with at least one visit in the period of drug discontinuation during the 40 week open label treatment phase.</p>
</div></div></section><p>Three deaths (1%) occurred in the anrikefon group and five (2%) in the placebo group during the double blind treatment phase. Moreover, 20 deaths (4.5%) occurred during the open label extension phase (<a href="#tbl3" class="usa-link">table 3</a>). Supplementary table S6 provides detailed data.</p></section></section><section id="sec23"><h2 class="pmc_sec_title">Discussion</h2>
<p>In the present phase 3 (Anrikefon-302) trial, anrikefon led to a statistically significant improvement in pruritus intensity and itch related quality of life in patients with CKD associated pruritus undergoing haemodialysis, compared with placebo. The improvements in quality of life persisted throughout the 52 weeks of treatment. Moreover, anrikefon was well tolerated throughout the double blind and open label treatment phases.</p>
<p>The discovery of imbalance between kappa opioid receptor and mu opioid receptor signalling in pruritus facilitated the development of kappa opioid receptor agonists as potential treatment strategies for CKD associated pruritus.<a href="#ref17" class="usa-link" aria-describedby="ref17"><sup>17</sup></a>
<a href="#ref18" class="usa-link" aria-describedby="ref18"><sup>18</sup></a> A preclinical study suggested that anrikefon could be a potent effective kappa opioid receptor agonist for relieving itching.<a href="#ref19" class="usa-link" aria-describedby="ref19"><sup>19</sup></a> Furthermore, a multicentre double blind randomised placebo controlled phase 2a trial indicated that anrikefon was well tolerated in the dose range of 0.05-0.80 μg/kg in patients undergoing haemodialysis,<a href="#ref14" class="usa-link" aria-describedby="ref14"><sup>14</sup></a> making it a promising candidate for managing CKD associated pruritus. The present phase 3 trial showed a more important effect of anrikefon on CKD associated pruritus in Chinese patients with moderate to severe pruritus undergoing haemodialysis. Anrikefon statistically significantly reduced itch intensity and improved itch related quality of life in these patients.</p>
<section id="sec24"><h3 class="pmc_sec_title">Comparison with other studies</h3>
<p>Difelikefalin, a synthetic peptide agonist of the kappa opioid receptor, has been approved in the US and Europe for the treatment of CKD associated moderate to severe pruritus in adults undergoing haemodialysis.<a href="#ref20" class="usa-link" aria-describedby="ref20"><sup>20</sup></a> Notably, anrikefon has a spiral ring structural modification, which improves the binding affinity of kappa opioid receptor, providing stronger agonistic activity.<a href="#ref19" class="usa-link" aria-describedby="ref19"><sup>19</sup></a> An in vitro study revealed that the agonistic activity of anrikefon was more than 12 times higher than that of difelikefalin.<a href="#ref19" class="usa-link" aria-describedby="ref19"><sup>19</sup></a> Moreover, the treatment dose of anrikefon was lower than that of difelikefalin (0.3 μg/kg <em>v</em> 0.5 μg/kg).<a href="#ref21" class="usa-link" aria-describedby="ref21"><sup>21</sup></a>
<a href="#ref22" class="usa-link" aria-describedby="ref22"><sup>22</sup></a> Importantly, the present phase 3 trial showed that anrikefon’s efficacy with a lower treatment dose was comparable to that of difelikefalin (37.2% <em>v</em> 37.1%) in treating pruritus in patients undergoing haemodialysis.<a href="#ref21" class="usa-link" aria-describedby="ref21"><sup>21</sup></a>
</p>
<p>Anrikefon’s high affinity for peripheral kappa opioid receptors makes it a potentially safe and effective treatment for CKD associated pruritus. However, the long term effects of kappa opioid receptor agonists remain unknown. In addition to the 12 week double blind treatment phase, the present trial included a 40 week open label extension phase, offering a comprehensive assessment of anrikefon’s long term efficacy and safety. The sustained improvement observed in the open label extension phase at week 40 supports the long term efficacy of anrikefon in managing pruritus. This investigation therefore provided critical evidence for the efficacy and safety of long term treatment with anrikefon in patients with CKD associated pruritus undergoing haemodialysis.</p>
<p>In this trial, although the adverse event of dizziness seemed to be more frequent in patients receiving anrikefon compared with placebo, most of the treatment emergent adverse events were mild to moderate. Importantly, the treatment emergent adverse events did not increase with prolonged use of anrikefon. Moreover, the incidence of diarrhoea did not increase, which was reported in patients receiving difelikefalin.<a href="#ref21" class="usa-link" aria-describedby="ref21"><sup>21</sup></a> During the open label extension phase, the incidence of treatment emergent adverse events did not statistically significantly increase despite longer use of anrikefon. The types and rates of adverse events, including serious adverse events and those with higher incidence, were largely consistent between the anrikefon group and placebo group. In addition, no dysphoria or hallucination events were observed, both of which are well documented adverse events associated with centrally acting kappa opioid receptor agonists.<a href="#ref23" class="usa-link" aria-describedby="ref23"><sup>23</sup></a>
<a href="#ref24" class="usa-link" aria-describedby="ref24"><sup>24</sup></a> Thus, anrikefon was well tolerated, even with prolonged use.</p></section><section id="sec25"><h3 class="pmc_sec_title">Strengths and limitations of this study</h3>
<p>Given the pharmacological characteristics of kappa opioid receptor agonists, the potential physical dependence associated with long term use remains a concern.<a href="#ref25" class="usa-link" aria-describedby="ref25"><sup>25</sup></a> A preclinical study specifically designed to evaluate the addictive properties of anrikefon suggested a low probability of misuse.<a href="#ref26" class="usa-link" aria-describedby="ref26"><sup>26</sup></a> In a phase 2 trial, no withdrawal symptoms were detected throughout the two week discontinuation period, as measured by the short opioid withdrawal scale and objective opioid withdrawal scale scores (unpublished data), which further confirmed the low potential for misuse. Taken together, these data indicate that long term use of kappa opioid receptor agonists is potentially safe for patients with CKD associated pruritus undergoing haemodialysis.</p>
<p>This study has several limitations. Firstly, it exclusively enrolled patients with end stage renal disease requiring haemodialysis. Therefore, the efficacy and safety of anrikefon in patients with non-dialysis dependent CKD remain to be investigated. Secondly, the implications for discontinuation of long term treatment and the potential for physical dependence associated with long term treatment with kappa opioid receptor agonists were not evaluated. Thirdly, this was a placebo controlled trial. An active controlled trial comparing the drug with established treatments should be further conducted. Although residual placebo effects cannot be entirely excluded, rigorous standardisation of methods minimised the impact of these effects on the trial outcomes. Finally, the open label design during the extension phase could have introduced bias in adverse event reporting by both patients and investigators.</p></section><section id="sec26"><h3 class="pmc_sec_title">Conclusions</h3>
<p>This phase 3 trial showed that a new peripheral kappa opioid receptor agonist, anrikefon, could statistically significantly reduce the intensity of pruritus and improve the quality of life of patients with moderate to severe CKD associated pruritus undergoing haemodialysis. The sustained therapeutic effect and low incidence of central opioid adverse reactions make anrikefon a promising new treatment option for patients with CKD associated pruritus.</p>
<section class="bt xbox font-sm" id="boxa"><section id="sec27"><h4 class="pmc_sec_title">What is already known on this topic</h4>
<ul id="L1" class="list" style="list-style-type:none">
<li><p>Kappa opioid receptor agonist is considered a promising strategy for managing moderate to severe CKD associated pruritus</p></li>
<li><p>Anrikefon (formerly known as HSK21542), a novel selective peripherally restricted kappa opioid receptor agonist, has a hydrophilic small peptide and spirocyclic structure that enhances its binding affinity to the kappa opioid receptor</p></li>
</ul></section><section id="sec28"><h4 class="pmc_sec_title">What this study adds</h4>
<ul id="L2" class="list" style="list-style-type:none">
<li><p>Anrikefon was found to be safe in patients with moderate to severe pruritus undergoing haemodialysis</p></li>
<li><p>Patients experienced a noticeable reduction in itch intensity and improvement in itch related quality of life</p></li>
<li><p>The continuous treatment effect and low incidence of central opioid adverse reactions with anrikefon suggest it would be a promising new treatment option for patients with CKD associated pruritus</p></li>
</ul></section></section></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We thank the patients who participated in this trial. We thank Lu-Yin Sun, Shu Gao, and Wen-Tao Chen (for biostatistical consulting) and Ya-Ming Li (Department of Research and Development of Haisco Pharmaceutical Group, Sichuan, China) for their contribution to the conduct of this trial. We are also grateful to the following contributors from the other participating centres for their efforts in recruiting patients, carrying out follow-up visits, and data analysis: Gang Long (Tianjin People’s Hospital), Tie-Kun Yan (Tianjin Medical University General Hospital), Lei Liu (The First Affiliated Hospital of Bengbu Medical University), Hong-Li Jiang (The First Affiliated Hospital of Xi’an Jiaotong University), Xiao-Ping Wang (Jinan Central Hospital), De-Guang Wang (The Second Hospital of Anhui Medical University), Jian Huang (Jinhua Municipal Central Hospital), Li-Ying Miu (The First People’s Hospital of Changzhou), Xiao-Hui Wang (Fifth Hospital in Wuhan), Wen-Li Chen (The Central Hospital of Wuhan), Hong Liu (The Second Xiangya Hospital of Central South University), Wei Chen (The First Affiliated Hospital, Sun Yat-sen University), Yong-Zhi Xu (Affiliated Hospital of Guangdong Medical University), Yong Wei (Shandong Provincial Qianfoshan Hospital), Li Zhou (West China Hospital Sichuan University), Lu Lv (The First Affiliated Hospital of Guangdong Pharmaceutical University), Ling Wu (Xuzhou Central Hospital), Dong-Liang Zhang (Beijing Jishuitan Hospital), Bang-Ming Chen (Jiujiang Traditional Chinese Medicine Hospital), Hong-Li Lin (The First affiliated hospital of Dalian Medical University), Hua Zhou (Shengjing Hospital of China Medical University), Nan Mao (The First Affiliated Hospital of Chengdu Medical College), Qi Guo (The First Affiliated Hospital, Zhejiang University School of Medicine), Ping Luo (The Second Norman Bethune Hospital of Jilin University), Wei Ren (Anhui Provincial Hospital), Qi-Jun Wan (First Affiliated Hospital of Shenzhen University), Xin-Zhou Zhang (Shenzhen People’s Hospital), Fu-Yun Sun (Cangzhou Central Hospital), Yi Li (Dongguan People’s Hospital), Hong-Bo Li (Wuhan No. 1 Hospital), Xiao-Ling Wang (The Second Hospital Lanzhou University), and Shu-Tong Du (Cangzhou People’s Hospital).</p></section><section id="notes1"><h2>Web extra.</h2>
<p>Extra material supplied by authors</p>
<section class="sm xbox font-sm" id="supplementary-material1"><div class="caption p"><p>Supplementary information: Additional information, tables S1-S6, and figures S1 and S2</p></div>
<div class="media p" id="d67e1134"><div class="caption">
<a href="/articles/instance/12362199/bin/liub085208.ww1.pdf" data-ga-action="click_feat_suppl" class="usa-link">liub085208.ww1.pdf</a><sup> (381.4KB, pdf) </sup>
</div></div></section></section><section id="notes2"><section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn6"><p>Contributors: B-CL, Z-LL, and PZ contributed equally to this work and are co-first authors. BCL and JHC conceived and designed the trial and are co-corresponding authors with equal contribution. All authors contributed to data acquisition and analysis. ZLL and BCL prepared the initial draft of the manuscript, and the other authors wrote various sections. All authors revised the manuscript and approved the final version. The corresponding authors attest that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. JHC and BCL act as guarantors.</p></div>
<div class="fn p" id="fn7"><p>Funding: This trial was funded by the Haisco Pharmaceutical Group. The funder was not involved in the trial’s design, data collection and analysis, and interpretation.</p></div>
<div class="fn p" id="fn8"><p>Competing interests: All authors have completed the ICMJE uniform disclosure form at <a href="https://www.icmje.org/disclosure-of-interest/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.icmje.org/disclosure-of-interest/</a> and declare: support from Haisco Pharmaceutical Group; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</p></div>
<div class="fn p" id="fn9"><p>Transparency: The lead author (the manuscript’s guarantor) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.</p></div>
<div class="fn p" id="fn10"><p>Dissemination to participants and related patient and public communities: The results of this trial were presented in the plenary session of the 2024 American Society of Nephrology kidney week in San Diego, CA. Our group will facilitate dissemination to participants and provide a summary of the trial findings. Once this study is published, we will disseminate the results to the public through social media and write blogs to explain the results. We also plan to present the study outcomes at academic congresses in China and worldwide.</p></div>
<div class="fn p" id="fn11"><p>Provenance and peer review: Not commissioned; externally peer reviewed.</p></div>
</div></section></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Collaborators: Anrikefon-302 study collaborator group, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Long%20G%22%5BAuthor%5D" class="usa-link">Gang Long</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20TK%22%5BAuthor%5D" class="usa-link">Tie-Kun Yan</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20L%22%5BAuthor%5D" class="usa-link">Lei Liu</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20HL%22%5BAuthor%5D" class="usa-link">Hong-Li Jiang</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20XP%22%5BAuthor%5D" class="usa-link">Xiao-Ping Wang</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20DG%22%5BAuthor%5D" class="usa-link">De-Guang Wang</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20J%22%5BAuthor%5D" class="usa-link">Jian Huang</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miu%20LY%22%5BAuthor%5D" class="usa-link">Li-Ying Miu</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20XH%22%5BAuthor%5D" class="usa-link">Xiao-Hui Wang</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20WL%22%5BAuthor%5D" class="usa-link">Wen-Li Chen</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link">Hong Liu</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20W%22%5BAuthor%5D" class="usa-link">Wei Chen</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20YZ%22%5BAuthor%5D" class="usa-link">Yong-Zhi Xu</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wei%20Y%22%5BAuthor%5D" class="usa-link">Yong Wei</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20L%22%5BAuthor%5D" class="usa-link">Li Zhou</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lv%20L%22%5BAuthor%5D" class="usa-link">Lu Lv</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20L%22%5BAuthor%5D" class="usa-link">Ling Wu</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20DL%22%5BAuthor%5D" class="usa-link">Dong-Liang Zhang</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20BM%22%5BAuthor%5D" class="usa-link">Bang-Ming Chen</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20HL%22%5BAuthor%5D" class="usa-link">Hong-Li Lin</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20H%22%5BAuthor%5D" class="usa-link">Hua Zhou</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mao%20N%22%5BAuthor%5D" class="usa-link">Nan Mao</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guo%20Q%22%5BAuthor%5D" class="usa-link">Qi Guo</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20P%22%5BAuthor%5D" class="usa-link">Ping Luo</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ren%20W%22%5BAuthor%5D" class="usa-link">Wei Ren</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wan%20QJ%22%5BAuthor%5D" class="usa-link">Qi-Jun Wan</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20XZ%22%5BAuthor%5D" class="usa-link">Xin-Zhou Zhang</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20FY%22%5BAuthor%5D" class="usa-link">Fu-Yun Sun</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link">Yi Li</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20HB%22%5BAuthor%5D" class="usa-link">Hong-Bo Li</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20XL%22%5BAuthor%5D" class="usa-link">Xiao-Ling Wang</a>, and <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Du%20ST%22%5BAuthor%5D" class="usa-link">Shu-Tong Du</a></p></section><section id="sec29"><h2 class="pmc_sec_title">Ethics statements</h2>
<section id="sec30"><h3 class="pmc_sec_title">Ethical approval</h3>
<p>This study was approved by the ethics committee of the Clinical Research of the First Affiliated Hospital to Zhejiang University School of Medicine (approval No 2022-177), Zhongda Hospital Affiliated to Southeast University School of Medicine (approval No 2021ZDSYLL318-Y01), and all other participating centres. This trial was also conducted in accordance with the principles of the Declaration of Helsinki and the Good Clinical Practice guidelines. All participants provided written informed consent before trial participation.</p></section></section><section id="sec31"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The data underlying this article’s findings are openly and publicly available at <a href="https://doi.org/10.5061/dryad.rr4xgxdk8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.5061/dryad.rr4xgxdk8</a>. If you have difficulty accessing the data, please contact the corresponding authors.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="ref1">
<span class="label">1.</span><cite>
Faucon AL, Clase CM, Rydell H, et al. Burden of CKD-associated pruritus and adverse clinical outcomes in patients receiving dialysis: The Stockholm Creatinine Measurements (SCREAM) Project. Am J Kidney Dis
2025;85:45-54.e1. 10.1053/j.ajkd.2024.05.013 

</cite> [<a href="https://doi.org/10.1053/j.ajkd.2024.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39067660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Burden%20of%20CKD-associated%20pruritus%20and%20adverse%20clinical%20outcomes%20in%20patients%20receiving%20dialysis:%20The%20Stockholm%20Creatinine%20Measurements%20(SCREAM)%20Project&amp;author=AL%20Faucon&amp;author=CM%20Clase&amp;author=H%20Rydell&amp;volume=85&amp;publication_year=2025&amp;pages=45-54.e1&amp;pmid=39067660&amp;doi=10.1053/j.ajkd.2024.05.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref2">
<span class="label">2.</span><cite>
Sukul N, Zhao J, Pisoni RL, et al. Pruritus in hemodialysis patients: Longitudinal associations with clinical and patient-reported outcomes. Am J Kidney Dis
2023;82:666-76. 10.1053/j.ajkd.2023.04.008 

</cite> [<a href="https://doi.org/10.1053/j.ajkd.2023.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37777951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Pruritus%20in%20hemodialysis%20patients:%20Longitudinal%20associations%20with%20clinical%20and%20patient-reported%20outcomes&amp;author=N%20Sukul&amp;author=J%20Zhao&amp;author=RL%20Pisoni&amp;volume=82&amp;publication_year=2023&amp;pages=666-76&amp;pmid=37777951&amp;doi=10.1053/j.ajkd.2023.04.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref3">
<span class="label">3.</span><cite>
Scherer JS, Tu C, Pisoni RL, et al. CKDopps Investigators . CKD-associated pruritus and clinical outcomes in nondialysis CKD. Kidney Med
2023;6:100754. 10.1016/j.xkme.2023.100754 

</cite> [<a href="https://doi.org/10.1016/j.xkme.2023.100754" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10788264/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38225976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Med&amp;title=CKD-associated%20pruritus%20and%20clinical%20outcomes%20in%20nondialysis%20CKD&amp;author=JS%20Scherer&amp;author=C%20Tu&amp;author=RL%20Pisoni&amp;volume=6&amp;publication_year=2023&amp;pages=100754&amp;pmid=38225976&amp;doi=10.1016/j.xkme.2023.100754&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref4">
<span class="label">4.</span><cite>
Tennankore KK, McCullough KP, Bieber B, et al. Prevalence and outcomes of chronic kidney disease associated pruritus: international results from PDOPPS. Clin J Am Soc Nephrol
2024.. 
10.2215/CJN.0000000000000537. 

</cite> [<a href="https://doi.org/10.2215/CJN.0000000000000537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39392697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Prevalence%20and%20outcomes%20of%20chronic%20kidney%20disease%20associated%20pruritus:%20international%20results%20from%20PDOPPS&amp;author=KK%20Tennankore&amp;author=KP%20McCullough&amp;author=B%20Bieber&amp;publication_year=2024.&amp;pmid=39392697&amp;doi=10.2215/CJN.0000000000000537&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref5">
<span class="label">5.</span><cite>
Yosipovitch G. Chronic kidney disease-associated pruritus, still a vexing problem. NEJM Evid
2023;2:e2300227. 10.1056/EVIDe2300227 

</cite> [<a href="https://doi.org/10.1056/EVIDe2300227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38320532/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NEJM%20Evid&amp;title=Chronic%20kidney%20disease-associated%20pruritus,%20still%20a%20vexing%20problem&amp;author=G%20Yosipovitch&amp;volume=2&amp;publication_year=2023&amp;pages=e2300227&amp;pmid=38320532&amp;doi=10.1056/EVIDe2300227&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref6">
<span class="label">6.</span><cite>
Sukul N, Karaboyas A, Csomor PA, et al. Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients. Kidney Med
2020;3:42-53.e1. 10.1016/j.xkme.2020.08.011 

</cite> [<a href="https://doi.org/10.1016/j.xkme.2020.08.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7873756/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33604539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Med&amp;title=Self-reported%20pruritus%20and%20clinical,%20dialysis-related,%20and%20patient-reported%20outcomes%20in%20hemodialysis%20patients&amp;author=N%20Sukul&amp;author=A%20Karaboyas&amp;author=PA%20Csomor&amp;volume=3&amp;publication_year=2020&amp;pages=42-53.e1&amp;pmid=33604539&amp;doi=10.1016/j.xkme.2020.08.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref7">
<span class="label">7.</span><cite>
Pisoni RL, Wikström B, Elder SJ, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant
2006;21:3495-505. 10.1093/ndt/gfl461 

</cite> [<a href="https://doi.org/10.1093/ndt/gfl461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16968725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Pruritus%20in%20haemodialysis%20patients:%20International%20results%20from%20the%20Dialysis%20Outcomes%20and%20Practice%20Patterns%20Study%20(DOPPS)&amp;author=RL%20Pisoni&amp;author=B%20Wikstr%C3%B6m&amp;author=SJ%20Elder&amp;volume=21&amp;publication_year=2006&amp;pages=3495-505&amp;pmid=16968725&amp;doi=10.1093/ndt/gfl461&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref8">
<span class="label">8.</span><cite>
Brennan F. The pathogenesis of CKD-associated pruritus: A theoretical model and relevance for treatment. Kidney360
2024;5:1727-38. 10.34067/KID.0000000573 

</cite> [<a href="https://doi.org/10.34067/KID.0000000573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12282631/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39230964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney360&amp;title=The%20pathogenesis%20of%20CKD-associated%20pruritus:%20A%20theoretical%20model%20and%20relevance%20for%20treatment&amp;author=F%20Brennan&amp;volume=5&amp;publication_year=2024&amp;pages=1727-38&amp;pmid=39230964&amp;doi=10.34067/KID.0000000573&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref9">
<span class="label">9.</span><cite>
Verduzco HA, Shirazian S. CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management. Kidney Int Rep
2020;5:1387-402. 10.1016/j.ekir.2020.04.027 

</cite> [<a href="https://doi.org/10.1016/j.ekir.2020.04.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7486142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32954065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Rep&amp;title=CKD-associated%20pruritus:%20new%20insights%20into%20diagnosis,%20pathogenesis,%20and%20management&amp;author=HA%20Verduzco&amp;author=S%20Shirazian&amp;volume=5&amp;publication_year=2020&amp;pages=1387-402&amp;pmid=32954065&amp;doi=10.1016/j.ekir.2020.04.027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref10">
<span class="label">10.</span><cite>
Kim BS, Inan S, Ständer S, Sciascia T, Szepietowski JC, Yosipovitch G. Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits. Exp Dermatol
2022;31:1900-7. 10.1111/exd.14669 

</cite> [<a href="https://doi.org/10.1111/exd.14669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10087456/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36054458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Dermatol&amp;title=Role%20of%20kappa-opioid%20and%20mu-opioid%20receptors%20in%20pruritus:%20Peripheral%20and%20central%20itch%20circuits&amp;author=BS%20Kim&amp;author=S%20Inan&amp;author=S%20St%C3%A4nder&amp;author=T%20Sciascia&amp;author=JC%20Szepietowski&amp;volume=31&amp;publication_year=2022&amp;pages=1900-7&amp;pmid=36054458&amp;doi=10.1111/exd.14669&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref11">
<span class="label">11.</span><cite>
Sutaria N, Adawi W, Goldberg R, Roh YS, Choi J, Kwatra SG. Itch: Pathogenesis and treatment. J Am Acad Dermatol
2022;86:17-34. 10.1016/j.jaad.2021.07.078 

</cite> [<a href="https://doi.org/10.1016/j.jaad.2021.07.078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34648873/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Acad%20Dermatol&amp;title=Itch:%20Pathogenesis%20and%20treatment&amp;author=N%20Sutaria&amp;author=W%20Adawi&amp;author=R%20Goldberg&amp;author=YS%20Roh&amp;author=J%20Choi&amp;volume=86&amp;publication_year=2022&amp;pages=17-34&amp;pmid=34648873&amp;doi=10.1016/j.jaad.2021.07.078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref12">
<span class="label">12.</span><cite>
Shao R, Wang HY, Ruan ZR, et al. Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers. Basic Clin Pharmacol Toxicol
2024;135:743-54. 10.1111/bcpt.14094 

</cite> [<a href="https://doi.org/10.1111/bcpt.14094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39397291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20Clin%20Pharmacol%20Toxicol&amp;title=Phase%20I%20clinical%20trial%20evaluating%20the%20safety,%20tolerance,%20pharmacokinetics%20and%20pharmacodynamics%20of%20HSK21542%20injection%20in%20healthy%20volunteers&amp;author=R%20Shao&amp;author=HY%20Wang&amp;author=ZR%20Ruan&amp;volume=135&amp;publication_year=2024&amp;pages=743-54&amp;pmid=39397291&amp;doi=10.1111/bcpt.14094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref13">
<span class="label">13.</span><cite>
Zhang M, Lei Z, Yao X, et al. Model informed drug development: HSK21542 PBPK model supporting dose decisions in specific populations. Eur J Pharm Sci
2024;196:106763. 10.1016/j.ejps.2024.106763 

</cite> [<a href="https://doi.org/10.1016/j.ejps.2024.106763" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38599505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pharm%20Sci&amp;title=Model%20informed%20drug%20development:%20HSK21542%20PBPK%20model%20supporting%20dose%20decisions%20in%20specific%20populations&amp;author=M%20Zhang&amp;author=Z%20Lei&amp;author=X%20Yao&amp;volume=196&amp;publication_year=2024&amp;pages=106763&amp;pmid=38599505&amp;doi=10.1016/j.ejps.2024.106763&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref14">
<span class="label">14.</span><cite>
Pan M, Wang G, Zhou L, et al. Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study. Front Pharmacol
2023;14:1203642. 10.3389/fphar.2023.1203642 

</cite> [<a href="https://doi.org/10.3389/fphar.2023.1203642" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10590914/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37876731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Safety%20and%20effectiveness%20of%20HSK21542%20for%20hemodialysis%20patients:%20a%20multiple%20ascending%20dose%20study&amp;author=M%20Pan&amp;author=G%20Wang&amp;author=L%20Zhou&amp;volume=14&amp;publication_year=2023&amp;pages=1203642&amp;pmid=37876731&amp;doi=10.3389/fphar.2023.1203642&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref15">
<span class="label">15.</span><cite>The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Medical Dictionary for Regulatory Activities (MedDRA). <a href="https://admin.new.meddra.org/sites/default/files/guidance/file/dist_file_format_27_0.pdf.AccessedMar2024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://admin.new.meddra.org/sites/default/files/guidance/file/dist_file_format_27_0.pdf. Accessed Mar 2024</a>).</cite>
</li>
<li id="ref16">
<span class="label">16.</span><cite>US National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). https://dctd.cancer.gov/research/ctep-trials/for-sites/adverse-events/ctcae-v5-5x7.pdf. Accessed 27 Nov 2017</cite>
</li>
<li id="ref17">
<span class="label">17.</span><cite>
Latus J, Lanot A, Ständer S, Sanchez-Alvarez E, Aucella F, Yosipovitch G. CKD-associated pruritus in haemodialysis: a road map for diagnosis and treatment. Clin Kidney J
2025;18:sfaf096. 10.1093/ckj/sfaf096 

</cite> [<a href="https://doi.org/10.1093/ckj/sfaf096" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12080227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40376308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Kidney%20J&amp;title=CKD-associated%20pruritus%20in%20haemodialysis:%20a%20road%20map%20for%20diagnosis%20and%20treatment&amp;author=J%20Latus&amp;author=A%20Lanot&amp;author=S%20St%C3%A4nder&amp;author=E%20Sanchez-Alvarez&amp;author=F%20Aucella&amp;volume=18&amp;publication_year=2025&amp;pages=sfaf096&amp;pmid=40376308&amp;doi=10.1093/ckj/sfaf096&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref18">
<span class="label">18.</span><cite>
Mettang T, Kremer AE. Uremic pruritus. Kidney Int
2015;87:685-91. 10.1038/ki.2013.454 

</cite> [<a href="https://doi.org/10.1038/ki.2013.454" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24402092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Uremic%20pruritus&amp;author=T%20Mettang&amp;author=AE%20Kremer&amp;volume=87&amp;publication_year=2015&amp;pages=685-91&amp;pmid=24402092&amp;doi=10.1038/ki.2013.454&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref19">
<span class="label">19.</span><cite>
Wang X, Gou X, Yu X, et al. Antinociceptive and antipruritic effects of HSK21542, a peripherally-restricted kappa opioid receptor agonist, in animal models of pain and itch. Front Pharmacol
2021;12:773204. 10.3389/fphar.2021.773204 

</cite> [<a href="https://doi.org/10.3389/fphar.2021.773204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8635029/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34867403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Antinociceptive%20and%20antipruritic%20effects%20of%20HSK21542,%20a%20peripherally-restricted%20kappa%20opioid%20receptor%20agonist,%20in%20animal%20models%20of%20pain%20and%20itch&amp;author=X%20Wang&amp;author=X%20Gou&amp;author=X%20Yu&amp;volume=12&amp;publication_year=2021&amp;pages=773204&amp;pmid=34867403&amp;doi=10.3389/fphar.2021.773204&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref20">
<span class="label">20.</span><cite>
Deeks ED. Difelikefalin: First Approval. Drugs
2021;81:1937-44. 10.1007/s40265-021-01619-6 

</cite> [<a href="https://doi.org/10.1007/s40265-021-01619-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34674115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Difelikefalin:%20First%20Approval&amp;author=ED%20Deeks&amp;volume=81&amp;publication_year=2021&amp;pages=1937-44&amp;pmid=34674115&amp;doi=10.1007/s40265-021-01619-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref21">
<span class="label">21.</span><cite>
Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F, KALM-1 Trial Investigators . A phase 3 trial of Difelikefalin in hemodialysis patients with pruritus. N Engl J Med
2020;382:222-32. 10.1056/NEJMoa1912770 

</cite> [<a href="https://doi.org/10.1056/NEJMoa1912770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31702883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20phase%203%20trial%20of%20Difelikefalin%20in%20hemodialysis%20patients%20with%20pruritus&amp;author=S%20Fishbane&amp;author=A%20Jamal&amp;author=C%20Munera&amp;author=W%20Wen&amp;author=F%20Menzaghi&amp;volume=382&amp;publication_year=2020&amp;pages=222-32&amp;pmid=31702883&amp;doi=10.1056/NEJMoa1912770&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref22">
<span class="label">22.</span><cite>
Narita I, Tsubakihara Y, Takahashi N, et al. MR13A9-5 Trial Investigators . Difelikefalin for hemodialysis patients with pruritus in Japan. NEJM Evid
2023;2:a2300094. 10.1056/EVIDoa2300094 

</cite> [<a href="https://doi.org/10.1056/EVIDoa2300094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38320524/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NEJM%20Evid&amp;title=Difelikefalin%20for%20hemodialysis%20patients%20with%20pruritus%20in%20Japan&amp;author=I%20Narita&amp;author=Y%20Tsubakihara&amp;author=N%20Takahashi&amp;volume=2&amp;publication_year=2023&amp;pages=a2300094&amp;pmid=38320524&amp;doi=10.1056/EVIDoa2300094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref23">
<span class="label">23.</span><cite>
Chavkin C. The therapeutic potential of κ-opioids for treatment of pain and addiction. Neuropsychopharmacology
2011;36:369-70. 10.1038/npp.2010.137 

</cite> [<a href="https://doi.org/10.1038/npp.2010.137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3055513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21116263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=The%20therapeutic%20potential%20of%20%CE%BA-opioids%20for%20treatment%20of%20pain%20and%20addiction&amp;author=C%20Chavkin&amp;volume=36&amp;publication_year=2011&amp;pages=369-70&amp;pmid=21116263&amp;doi=10.1038/npp.2010.137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref24">
<span class="label">24.</span><cite>
Butelman ER, Kreek MJ. Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Front Pharmacol
2015;6:190.

</cite> [<a href="https://doi.org/10.3389/fphar.2015.00190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4561799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26441647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Salvinorin%20A,%20a%20kappa-opioid%20receptor%20agonist%20hallucinogen:%20pharmacology%20and%20potential%20template%20for%20novel%20pharmacotherapeutic%20agents%20in%20neuropsychiatric%20disorders&amp;author=ER%20Butelman&amp;author=MJ%20Kreek&amp;volume=6&amp;publication_year=2015&amp;pages=190&amp;pmid=26441647&amp;doi=10.3389/fphar.2015.00190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref25">
<span class="label">25.</span><cite>
Albert-Vartanian A, Boyd MR, Hall AL, et al. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
J Clin Pharm Ther
2016;41:371-82. 10.1111/jcpt.12404 

</cite> [<a href="https://doi.org/10.1111/jcpt.12404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27245498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Pharm%20Ther&amp;title=Will%20peripherally%20restricted%20kappa-opioid%20receptor%20agonists%20(pKORAs)%20relieve%20pain%20with%20less%20opioid%20adverse%20effects%20and%20abuse%20potential?&amp;author=A%20Albert-Vartanian&amp;author=MR%20Boyd&amp;author=AL%20Hall&amp;volume=41&amp;publication_year=2016&amp;pages=371-82&amp;pmid=27245498&amp;doi=10.1111/jcpt.12404&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref26">
<span class="label">26.</span><cite>
Gou X, Chen Y, Ye Q, et al. Preclinical evaluation of abuse potential of the peripherally-restricted kappa opioid receptor agonist HSK21542. Regul Toxicol Pharmacol
2024;154:105731. 10.1016/j.yrtph.2024.105731 

</cite> [<a href="https://doi.org/10.1016/j.yrtph.2024.105731" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39455048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Regul%20Toxicol%20Pharmacol&amp;title=Preclinical%20evaluation%20of%20abuse%20potential%20of%20the%20peripherally-restricted%20kappa%20opioid%20receptor%20agonist%20HSK21542&amp;author=X%20Gou&amp;author=Y%20Chen&amp;author=Q%20Ye&amp;volume=154&amp;publication_year=2024&amp;pages=105731&amp;pmid=39455048&amp;doi=10.1016/j.yrtph.2024.105731&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>Supplementary information: Additional information, tables S1-S6, and figures S1 and S2</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12362199/bin/liub085208.ww1.pdf" data-ga-action="click_feat_suppl" class="usa-link">liub085208.ww1.pdf</a><sup> (381.4KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data underlying this article’s findings are openly and publicly available at <a href="https://doi.org/10.5061/dryad.rr4xgxdk8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.5061/dryad.rr4xgxdk8</a>. If you have difficulty accessing the data, please contact the corresponding authors.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from The BMJ are provided here courtesy of <strong>BMJ Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1136/bmj-2025-085208"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12362199/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12362199/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12362199%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362199/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12362199/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12362199/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40829896/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12362199/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40829896/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12362199/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12362199/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="CxmU6Qql3o2h2Ca2yfckqtR3jXOZWHysErYg0ZBgh2hl8vFLKpp85GqI5McgMwLL">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
